Literature DB >> 12071726

Trehalose glass-facilitated thermal reduction of metmyoglobin and methemoglobin.

Anandhi Ray1, Benjamin A Friedman, Joel M Friedman.   

Abstract

The reduction of ferric derivatives of hemeproteins in solution typically requires moderate to strong reducing agents. Reducing sugars are not adequate to reduce ferric myoglobins or hemoglobins under solution conditions favorable to protein stability. We find that embedding aquo-met derivatives of horse myoglobin and human adult hemoglobin in a glucose-doped glassy matrix derived from trehalose facilitates an efficient thermally initiated reduction that yields a five-coordinate high-spin ferrous heme. The trehalose glass plays a central role by stabilizing the reduction-prone bis-histidine heme (hemichrome) intermediate under the high-temperature conditions that favor the open reducing form of glucose. Due to glass-imposed limitations on conformational reorganization, this process has clear applications in biophysics where it can be used to generate nonequilibrium ferrous derivatives having the initial conformation of the aquo-met derivative. Since the glassy matrix can be redissolved to release the embedded protein, this technique is not only a basis for a relatively benign method of reducing hemoglobin-based blood substitutes that have undergone autoxidation during storage but may also be a way to reactivate stored proteins that have undergone oxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071726     DOI: 10.1021/ja0201348

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  Glass matrix-facilitated thermal reduction: a tool for probing reactions of met hemoglobin with nitrite and nitric oxide.

Authors:  Mahantesh S Navati; Joel M Friedman
Journal:  J Phys Chem B       Date:  2010-03-04       Impact factor: 2.991

2.  Reactivity of glass-embedded met hemoglobin derivatives toward external NO: implications for nitrite-mediated production of bioactive NO.

Authors:  Mahantesh S Navati; Joel M Friedman
Journal:  J Am Chem Soc       Date:  2009-09-02       Impact factor: 15.419

3.  Sustained release nitric oxide from long-lived circulating nanoparticles.

Authors:  Pedro Cabrales; George Han; Camille Roche; Parimala Nacharaju; Adam J Friedman; Joel M Friedman
Journal:  Free Radic Biol Med       Date:  2010-05-09       Impact factor: 7.376

4.  Correlation between hemichrome stability and the root effect in tetrameric hemoglobins.

Authors:  Alessandro Vergara; Marisa Franzese; Antonello Merlino; Giovanna Bonomi; Cinzia Verde; Daniela Giordano; Guido di Prisco; H Caroline Lee; Jack Peisach; Lelio Mazzarella
Journal:  Biophys J       Date:  2009-08-05       Impact factor: 4.033

Review 5.  Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.

Authors:  Catherine DeMarino; Angela Schwab; Michelle Pleet; Allison Mathiesen; Joel Friedman; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-02       Impact factor: 4.147

Review 6.  The potential of nitric oxide releasing therapies as antimicrobial agents.

Authors:  David O Schairer; Jason S Chouake; Joshua D Nosanchuk; Adam J Friedman
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.